SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2MD'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NW5_A_SAMA401_0 (MODIFICATION METHYLASE RSRI)	1h0h	FORMATE DEHYDROGENASE SUBUNIT ALPHA (Desulfovibrio gigas)	5 / 12	TRP A 538 PHE A 513 GLY A 127 SER A 128 ALA A 124	None None None 2MD A1001 ( 4.3A) None	1.28A	1nw5A-1h0hA: undetectable	1nw5A-1h0hA: 16.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1P93_A_DEXA1999_1 (GLUCOCORTICOID RECEPTOR)	2iv2	FORMATE DEHYDROGENASE H (Escherichia coli)	5 / 12	GLY X 334 GLN X 335 GLN X 463 THR X 36 ILE X 161	MGD X 802 ( 3.3A) 2MD X 801 (-3.2A) None None None	1.34A	1p93A-2iv2X: undetectable	1p93A-2iv2X: 17.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SQF_A_SAMA430_1 (SUN PROTEIN)	1tmo	TRIMETHYLAMINE N-OXIDE REDUCTASE (Shewanella massilia)	3 / 3	PRO A 246 ASP A 249 ASP A 227	None 2MD A 800 (-3.1A) 2MD A 800 (-2.8A)	0.81A	1sqfA-1tmoA: undetectable	1sqfA-1tmoA: 19.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AOX_A_THAA400_1 (HISTAMINE N-METHYLTRANSFERASE)	1tmo	TRIMETHYLAMINE N-OXIDE REDUCTASE (Shewanella massilia)	4 / 8	PHE A 16 GLN A 659 TRP A 118 TRP A 198	None 2MD A 799 (-3.7A) 2MO A 801 ( 3.9A) None	1.22A	2aoxA-1tmoA: 2.4	2aoxA-1tmoA: 15.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AOX_B_THAB401_1 (HISTAMINE N-METHYLTRANSFERASE)	1tmo	TRIMETHYLAMINE N-OXIDE REDUCTASE (Shewanella massilia)	4 / 7	PHE A 16 GLN A 659 TRP A 118 TRP A 198	None 2MD A 799 (-3.7A) 2MO A 801 ( 3.9A) None	1.21A	2aoxB-1tmoA: 2.6	2aoxB-1tmoA: 15.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2F16_2_BO221405_1 (PROTEASOME COMPONENT PRE3)	1tmo	TRIMETHYLAMINE N-OXIDE REDUCTASE (Shewanella massilia)	5 / 11	THR A 474 THR A 472 ALA A 473 SER A 440 GLY A 441	None 2MD A 799 (-4.0A) None 2MD A 799 ( 4.4A) 2MD A 799 (-3.7A)	1.21A	2f162-1tmoA: undetectable	2f162-1tmoA: 12.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2F16_N_BO2N1404_1 (PROTEASOME COMPONENT PRE3)	1tmo	TRIMETHYLAMINE N-OXIDE REDUCTASE (Shewanella massilia)	5 / 11	THR A 474 THR A 472 ALA A 473 SER A 440 GLY A 441	None 2MD A 799 (-4.0A) None 2MD A 799 ( 4.4A) 2MD A 799 (-3.7A)	1.20A	2f16N-1tmoA: undetectable	2f16N-1tmoA: 12.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FT9_A_CHDA131_0 (FATTY ACID-BINDING PROTEIN 2, LIVER)	1h0h	FORMATE DEHYDROGENASE SUBUNIT ALPHA (Desulfovibrio gigas)	5 / 11	TYR A 139 LEU A 143 LEU A 148 PRO A 519 LEU A 612	None None None 2MD A1001 ( 4.9A) None	1.22A	2ft9A-1h0hA: 0.0	2ft9A-1h0hA: 9.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QBM_A_CAMA517_0 (CYTOCHROME P450-CAM)	1tmo	TRIMETHYLAMINE N-OXIDE REDUCTASE (Shewanella massilia)	5 / 8	PHE A 524 VAL A 465 THR A 466 ASP A 520 ILE A 523	None None None 2MD A 799 (-3.4A) None	1.22A	2qbmA-1tmoA: undetectable	2qbmA-1tmoA: 18.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3A25_A_SAMA279_1 (UNCHARACTERIZED PROTEIN PH0793)	1tmo	TRIMETHYLAMINE N-OXIDE REDUCTASE (Shewanella massilia)	3 / 3	MET A 43 GLU A 662 ASP A 468	None None 2MD A 799 (-3.1A)	1.04A	3a25A-1tmoA: undetectable	3a25A-1tmoA: 17.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BJW_E_SVRE510_3 (PHOSPHOLIPASE A2)	1h0h	FORMATE DEHYDROGENASE SUBUNIT ALPHA (Desulfovibrio gigas)	4 / 5	VAL A 905 THR A 975 THR A 954 ARG A 906	None None 2MD A1001 ( 4.4A) None	1.23A	3bjwG-1h0hA: 0.0	3bjwG-1h0hA: 8.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3K2H_B_LYAB514_2 (DIHYDROFOLATE REDUCTASE/THYMIDYLAT E SYNTHASE)	1h0h	FORMATE DEHYDROGENASE SUBUNIT ALPHA (Desulfovibrio gigas)	3 / 3	ARG A 156 THR A 854 THR A 529	None 2MD A1001 (-3.3A) None	0.71A	3k2hB-1h0hA: undetectable	3k2hB-1h0hA: 19.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MG0_2_BO221405_1 (PROTEASOME COMPONENT PRE3 PROTEASOME COMPONENT PUP1)	1tmo	TRIMETHYLAMINE N-OXIDE REDUCTASE (Shewanella massilia)	5 / 12	THR A 474 THR A 472 ALA A 473 SER A 440 GLY A 441	None 2MD A 799 (-4.0A) None 2MD A 799 ( 4.4A) 2MD A 799 (-3.7A)	1.16A	3mg02-1tmoA: undetectable 3mg0V-1tmoA: undetectable	3mg02-1tmoA: 12.92 3mg0V-1tmoA: 14.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MG0_N_BO2N1404_1 (PROTEASOME COMPONENT PRE3)	1tmo	TRIMETHYLAMINE N-OXIDE REDUCTASE (Shewanella massilia)	5 / 11	THR A 474 THR A 472 ALA A 473 SER A 440 GLY A 441	None 2MD A 799 (-4.0A) None 2MD A 799 ( 4.4A) 2MD A 799 (-3.7A)	1.16A	3mg0N-1tmoA: undetectable	3mg0N-1tmoA: 12.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TM4_A_SAMA401_1 (TRNA (GUANINE N2-)-METHYLTRANSFERA SE TRM14)	2iv2	FORMATE DEHYDROGENASE H (Escherichia coli)	4 / 5	HIS X 451 THR X 6 GLU X 450 ASP X 54	2MD X 801 (-4.7A) None None None	1.41A	3tm4A-2iv2X: undetectable	3tm4A-2iv2X: 20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TM4_B_SAMB401_1 (TRNA (GUANINE N2-)-METHYLTRANSFERA SE TRM14)	2iv2	FORMATE DEHYDROGENASE H (Escherichia coli)	4 / 5	HIS X 451 THR X 6 GLU X 450 ASP X 54	2MD X 801 (-4.7A) None None None	1.38A	3tm4B-2iv2X: undetectable	3tm4B-2iv2X: 20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4A83_A_DXCA1160_0 (MAJOR POLLEN ALLERGEN BET V 1-A)	2iv2	FORMATE DEHYDROGENASE H (Escherichia coli)	5 / 12	PHE X 462 PHE X 455 GLN X 335 ALA X 341 MET X 344	None None 2MD X 801 (-3.2A) None None	1.39A	4a83A-2iv2X: undetectable	4a83A-2iv2X: 12.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AZS_A_SAMA1475_1 (METHYLTRANSFERASE WBDD)	2iv2	FORMATE DEHYDROGENASE H (Escherichia coli)	3 / 3	ARG X 68 ASP X 404 GLN X 407	None 2MD X 801 (-4.7A) None	0.87A	4azsA-2iv2X: undetectable	4azsA-2iv2X: 22.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IKJ_B_SUZB201_1 (TRANSTHYRETIN)	1tmo	TRIMETHYLAMINE N-OXIDE REDUCTASE (Shewanella massilia)	4 / 8	SER A 129 SER A 127 ALA A 381 SER A 126	None 2MD A 799 (-3.4A) None None	0.64A	4ikjA-1tmoA: undetectable 4ikjB-1tmoA: undetectable	4ikjA-1tmoA: 11.32 4ikjB-1tmoA: 11.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IKK_A_SUZA201_1 (TRANSTHYRETIN)	1tmo	TRIMETHYLAMINE N-OXIDE REDUCTASE (Shewanella massilia)	4 / 8	ALA A 381 SER A 126 SER A 129 SER A 127	None None None 2MD A 799 (-3.4A)	0.71A	4ikkA-1tmoA: undetectable 4ikkB-1tmoA: undetectable	4ikkA-1tmoA: 11.32 4ikkB-1tmoA: 11.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4JD6_A_TOYA501_1 (ENHANCED INTRACELLULAR SURVIVAL PROTEIN)	1h0h	FORMATE DEHYDROGENASE SUBUNIT ALPHA (Desulfovibrio gigas)	5 / 9	ASP A 605 ILE A 609 TRP A 142 SER A 125 VAL A 126	2MD A1001 (-2.8A) None None None None	1.50A	4jd6A-1h0hA: 0.0	4jd6A-1h0hA: 17.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4JVL_A_ESTA702_1 (ESTROGEN SULFOTRANSFERASE)	2iv2	FORMATE DEHYDROGENASE H (Escherichia coli)	4 / 9	TYR X 10 CYH X 588 HIS X 585 ILE X 430	None 2MD X 801 (-4.2A) None 2MD X 801 (-4.2A)	1.24A	4jvlA-2iv2X: undetectable	4jvlA-2iv2X: 17.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N48_A_SAMA601_0 (CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1)	2iv2	FORMATE DEHYDROGENASE H (Escherichia coli)	5 / 12	GLY X 113 GLY X 111 THR X 116 ASN X 114 GLY X 107	None 2MD X 801 (-3.8A) None None None	1.15A	4n48A-2iv2X: undetectable	4n48A-2iv2X: 21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N48_B_SAMB601_0 (CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1)	2iv2	FORMATE DEHYDROGENASE H (Escherichia coli)	5 / 12	GLY X 113 GLY X 111 THR X 116 ASN X 114 GLY X 107	None 2MD X 801 (-3.8A) None None None	1.12A	4n48B-2iv2X: undetectable	4n48B-2iv2X: 21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ZZC_A_ACTA401_0 (PROTON-GATED ION CHANNEL)	2iv2	FORMATE DEHYDROGENASE H (Escherichia coli)	4 / 6	ILE X 430 PHE X 431 ARG X 61 ILE X 52	2MD X 801 (-4.2A) None None None	1.00A	4zzcA-2iv2X: undetectable 4zzcB-2iv2X: undetectable	4zzcA-2iv2X: 17.87 4zzcB-2iv2X: 17.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ZZC_B_ACTB401_0 (PROTON-GATED ION CHANNEL)	2iv2	FORMATE DEHYDROGENASE H (Escherichia coli)	4 / 6	ILE X 430 PHE X 431 ARG X 61 ILE X 52	2MD X 801 (-4.2A) None None None	1.08A	4zzcB-2iv2X: undetectable 4zzcC-2iv2X: undetectable	4zzcB-2iv2X: 17.87 4zzcC-2iv2X: 17.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AMI_B_EF2B151_1 (CEREBLON ISOFORM 4)	1tmo	TRIMETHYLAMINE N-OXIDE REDUCTASE (Shewanella massilia)	4 / 8	ASN A 443 PRO A 444 PHE A 439 SER A 440	2MD A 799 (-4.5A) None None 2MD A 799 ( 4.4A)	0.65A	5amiB-1tmoA: undetectable	5amiB-1tmoA: 9.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EDL_A_VIBA201_1 (PUTATIVE HMP/THIAMINE PERMEASE PROTEIN YKOE)	2iv2	FORMATE DEHYDROGENASE H (Escherichia coli)	5 / 12	TYR X 10 TRP X 448 ILE X 430 SER X 590 ARG X 110	None None 2MD X 801 (-4.2A) 2MD X 801 (-3.2A) 2MD X 801 (-4.4A)	1.47A	5edlA-2iv2X: 0.6	5edlA-2iv2X: 15.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IKR_B_ID8B602_2 (PROSTAGLANDIN G/H SYNTHASE 2)	2iv2	FORMATE DEHYDROGENASE H (Escherichia coli)	3 / 3	SER X 445 LEU X 75 MET X 66	2MD X 801 (-2.9A) None None	0.70A	5ikrB-2iv2X: undetectable	5ikrB-2iv2X: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LF7_B_6V8B304_0 (PROTEASOME SUBUNIT BETA TYPE-6 PROTEASOME SUBUNIT BETA TYPE-7)	1tmo	TRIMETHYLAMINE N-OXIDE REDUCTASE (Shewanella massilia)	5 / 12	THR A 474 THR A 472 ALA A 473 SER A 440 GLY A 441	None 2MD A 799 (-4.0A) None 2MD A 799 ( 4.4A) 2MD A 799 (-3.7A)	1.13A	5lf7V-1tmoA: undetectable 5lf7b-1tmoA: undetectable	5lf7V-1tmoA: 14.23 5lf7b-1tmoA: 14.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LF7_N_6V8N305_0 (PROTEASOME SUBUNIT BETA TYPE-6 PROTEASOME SUBUNIT BETA TYPE-7)	1tmo	TRIMETHYLAMINE N-OXIDE REDUCTASE (Shewanella massilia)	5 / 12	THR A 474 THR A 472 ALA A 473 SER A 440 GLY A 441	None 2MD A 799 (-4.0A) None 2MD A 799 ( 4.4A) 2MD A 799 (-3.7A)	1.13A	5lf7H-1tmoA: undetectable 5lf7N-1tmoA: undetectable	5lf7H-1tmoA: 14.23 5lf7N-1tmoA: 14.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5N0O_A_SAMA501_1 (PEPTIDE N-METHYLTRANSFERASE)	1tmo	TRIMETHYLAMINE N-OXIDE REDUCTASE (Shewanella massilia)	3 / 3	ALA A 152 GLN A 333 THR A 761	None 2MD A 800 (-3.5A) None	0.71A	5n0oA-1tmoA: undetectable	5n0oA-1tmoA: 18.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5N4T_B_BEZB306_0 (BETA-LACTAMASE VIM-2)	1tmo	TRIMETHYLAMINE N-OXIDE REDUCTASE (Shewanella massilia)	3 / 3	HIS A 447 ASN A 446 ALA A 473	2MD A 799 (-4.2A) 2MD A 799 (-3.8A) None	0.74A	5n4tB-1tmoA: undetectable	5n4tB-1tmoA: 14.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XPR_A_K86A1201_2 (ENDOTHELIN B RECEPTOR,ENDOLYSIN,E NDOTHELIN B RECEPTOR)	1tmo	TRIMETHYLAMINE N-OXIDE REDUCTASE (Shewanella massilia)	4 / 4	ASP A 189 PRO A 652 GLU A 724 TYR A 771	None 2MD A 800 (-4.1A) 2MD A 799 ( 4.5A) 2MD A 799 (-4.8A)	1.44A	5xprA-1tmoA: 0.0	5xprA-1tmoA: 20.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GIQ_T_PCFT101_0 (CYTOCHROME B-C1 COMPLEX SUBUNIT 1, MITOCHONDRIAL CYTOCHROME B-C1 COMPLEX SUBUNIT 9 CYTOCHROME B-C1 COMPLEX SUBUNIT RIESKE, MITOCHONDRIAL)	1tmo	TRIMETHYLAMINE N-OXIDE REDUCTASE (Shewanella massilia)	4 / 8	MET A 50 GLY A 441 SER A 127 VAL A 469	None 2MD A 799 (-3.7A) 2MD A 799 (-3.4A) None	0.94A	6giqL-1tmoA: undetectable 6giqP-1tmoA: undetectable 6giqT-1tmoA: undetectable	6giqL-1tmoA: 20.64 6giqP-1tmoA: 13.75 6giqT-1tmoA: 6.20

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1NW5_A_SAMA401_0","MODIFICATION METHYLASE RSRI","1h0h","FORMATE DEHYDROGENASE SUBUNIT ALPHA","Desulfovibrio gigas",5,"TRP A 538;PHE A 513;GLY A 127;SER A 128;ALA A 124","None;None;None;2MD A1001 ( 4.3A);None","1.28A","1nw5A-1h0hA:undetectable",null],["1P93_A_DEXA1999_1","GLUCOCORTICOID RECEPTOR","2iv2","FORMATE DEHYDROGENASE H","Escherichia coli",5,"GLY X 334;GLN X 335;GLN X 463;THR X  36;ILE X 161","MGD X 802 ( 3.3A);2MD X 801 (-3.2A);None;None;None","1.34A","1p93A-2iv2X:undetectable","1nw5A-1h0hA:16.06"],["1SQF_A_SAMA430_1","SUN PROTEIN","1tmo","TRIMETHYLAMINE N-OXIDE REDUCTASE","Shewanella massilia",3,"PRO A 246;ASP A 249;ASP A 227","None;2MD A 800 (-3.1A);2MD A 800 (-2.8A)","0.81A","1sqfA-1tmoA:undetectable","1p93A-2iv2X:17.87"],["2AOX_A_THAA400_1","HISTAMINE N-METHYLTRANSFERASE","1tmo","TRIMETHYLAMINE N-OXIDE REDUCTASE","Shewanella massilia",4,"PHE A  16;GLN A 659;TRP A 118;TRP A 198","None;2MD A 799 (-3.7A);2MO A 801 ( 3.9A);None","1.22A","2aoxA-1tmoA:2.4","1sqfA-1tmoA:19.86"],["2AOX_B_THAB401_1","HISTAMINE N-METHYLTRANSFERASE","1tmo","TRIMETHYLAMINE N-OXIDE REDUCTASE","Shewanella massilia",4,"PHE A  16;GLN A 659;TRP A 118;TRP A 198","None;2MD A 799 (-3.7A);2MO A 801 ( 3.9A);None","1.21A","2aoxB-1tmoA:2.6","2aoxA-1tmoA:15.40"],["2F16_2_BO221405_1","PROTEASOME COMPONENT PRE3","1tmo","TRIMETHYLAMINE N-OXIDE REDUCTASE","Shewanella massilia",5,"THR A 474;THR A 472;ALA A 473;SER A 440;GLY A 441","None;2MD A 799 (-4.0A);None;2MD A 799 ( 4.4A);2MD A 799 (-3.7A)","1.21A","2f162-1tmoA:undetectable","2aoxB-1tmoA:15.40"],["2F16_N_BO2N1404_1","PROTEASOME COMPONENT PRE3","1tmo","TRIMETHYLAMINE N-OXIDE REDUCTASE","Shewanella massilia",5,"THR A 474;THR A 472;ALA A 473;SER A 440;GLY A 441","None;2MD A 799 (-4.0A);None;2MD A 799 ( 4.4A);2MD A 799 (-3.7A)","1.20A","2f16N-1tmoA:undetectable","2f162-1tmoA:12.92"],["2FT9_A_CHDA131_0","FATTY ACID-BINDING PROTEIN 2, LIVER","1h0h","FORMATE DEHYDROGENASE SUBUNIT ALPHA","Desulfovibrio gigas",5,"TYR A 139;LEU A 143;LEU A 148;PRO A 519;LEU A 612","None;None;None;2MD A1001 ( 4.9A);None","1.22A","2ft9A-1h0hA:0.0","2f16N-1tmoA:12.92"],["2QBM_A_CAMA517_0","CYTOCHROME P450-CAM","1tmo","TRIMETHYLAMINE N-OXIDE REDUCTASE","Shewanella massilia",5,"PHE A 524;VAL A 465;THR A 466;ASP A 520;ILE A 523","None;None;None;2MD A 799 (-3.4A);None","1.22A","2qbmA-1tmoA:undetectable","2ft9A-1h0hA:9.47"],["3A25_A_SAMA279_1","UNCHARACTERIZED PROTEIN PH0793","1tmo","TRIMETHYLAMINE N-OXIDE REDUCTASE","Shewanella massilia",3,"MET A  43;GLU A 662;ASP A 468","None;None;2MD A 799 (-3.1A)","1.04A","3a25A-1tmoA:undetectable","2qbmA-1tmoA:18.77"],["3BJW_E_SVRE510_3","PHOSPHOLIPASE A2;PHOSPHOLIPASE A2","1h0h","FORMATE DEHYDROGENASE SUBUNIT ALPHA","Desulfovibrio gigas",4,"VAL A 905;THR A 975;THR A 954;ARG A 906","None;None;2MD A1001 ( 4.4A);None","1.23A","3bjwG-1h0hA:0.0","3a25A-1tmoA:17.82"],["3K2H_B_LYAB514_2","DIHYDROFOLATE REDUCTASE\/THYMIDYLATE SYNTHASE","1h0h","FORMATE DEHYDROGENASE SUBUNIT ALPHA","Desulfovibrio gigas",3,"ARG A 156;THR A 854;THR A 529","None;2MD A1001 (-3.3A);None","0.71A","3k2hB-1h0hA:undetectable","3bjwG-1h0hA:8.00"],["3MG0_2_BO221405_1","PROTEASOME COMPONENT PRE3;PROTEASOME COMPONENT PUP1","1tmo","TRIMETHYLAMINE N-OXIDE REDUCTASE","Shewanella massilia",5,"THR A 474;THR A 472;ALA A 473;SER A 440;GLY A 441","None;2MD A 799 (-4.0A);None;2MD A 799 ( 4.4A);2MD A 799 (-3.7A)","1.16A","3mg02-1tmoA:undetectable;3mg0V-1tmoA:undetectable","3k2hB-1h0hA:19.62"],["3MG0_N_BO2N1404_1","PROTEASOME COMPONENT PRE3","1tmo","TRIMETHYLAMINE N-OXIDE REDUCTASE","Shewanella massilia",5,"THR A 474;THR A 472;ALA A 473;SER A 440;GLY A 441","None;2MD A 799 (-4.0A);None;2MD A 799 ( 4.4A);2MD A 799 (-3.7A)","1.16A","3mg0N-1tmoA:undetectable","3mg02-1tmoA:12.92;3mg0V-1tmoA:14.34"],["3TM4_A_SAMA401_1","TRNA (GUANINE N2-)-METHYLTRANSFERASE TRM14","2iv2","FORMATE DEHYDROGENASE H","Escherichia coli",4,"HIS X 451;THR X   6;GLU X 450;ASP X  54","2MD X 801 (-4.7A);None;None;None","1.41A","3tm4A-2iv2X:undetectable","3mg0N-1tmoA:12.92"],["3TM4_B_SAMB401_1","TRNA (GUANINE N2-)-METHYLTRANSFERASE TRM14","2iv2","FORMATE DEHYDROGENASE H","Escherichia coli",4,"HIS X 451;THR X   6;GLU X 450;ASP X  54","2MD X 801 (-4.7A);None;None;None","1.38A","3tm4B-2iv2X:undetectable","3tm4A-2iv2X:20.69"],["4A83_A_DXCA1160_0","MAJOR POLLEN ALLERGEN BET V 1-A","2iv2","FORMATE DEHYDROGENASE H","Escherichia coli",5,"PHE X 462;PHE X 455;GLN X 335;ALA X 341;MET X 344","None;None;2MD X 801 (-3.2A);None;None","1.39A","4a83A-2iv2X:undetectable","3tm4B-2iv2X:20.69"],["4AZS_A_SAMA1475_1","METHYLTRANSFERASE WBDD","2iv2","FORMATE DEHYDROGENASE H","Escherichia coli",3,"ARG X  68;ASP X 404;GLN X 407","None;2MD X 801 (-4.7A);None","0.87A","4azsA-2iv2X:undetectable","4a83A-2iv2X:12.09"],["4IKJ_B_SUZB201_1","TRANSTHYRETIN;TRANSTHYRETIN","1tmo","TRIMETHYLAMINE N-OXIDE REDUCTASE","Shewanella massilia",4,"SER A 129;SER A 127;ALA A 381;SER A 126","None;2MD A 799 (-3.4A);None;None","0.64A","4ikjA-1tmoA:undetectable;4ikjB-1tmoA:undetectable","4azsA-2iv2X:22.67"],["4IKK_A_SUZA201_1","TRANSTHYRETIN;TRANSTHYRETIN","1tmo","TRIMETHYLAMINE N-OXIDE REDUCTASE","Shewanella massilia",4,"ALA A 381;SER A 126;SER A 129;SER A 127","None;None;None;2MD A 799 (-3.4A)","0.71A","4ikkA-1tmoA:undetectable;4ikkB-1tmoA:undetectable","4ikjA-1tmoA:11.32;4ikjB-1tmoA:11.32"],["4JD6_A_TOYA501_1","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","1h0h","FORMATE DEHYDROGENASE SUBUNIT ALPHA","Desulfovibrio gigas",5,"ASP A 605;ILE A 609;TRP A 142;SER A 125;VAL A 126","2MD A1001 (-2.8A);None;None;None;None","1.50A","4jd6A-1h0hA:0.0","4ikkA-1tmoA:11.32;4ikkB-1tmoA:11.32"],["4JVL_A_ESTA702_1","ESTROGEN SULFOTRANSFERASE","2iv2","FORMATE DEHYDROGENASE H","Escherichia coli",4,"TYR X  10;CYH X 588;HIS X 585;ILE X 430","None;2MD X 801 (-4.2A);None;2MD X 801 (-4.2A)","1.24A","4jvlA-2iv2X:undetectable","4jd6A-1h0hA:17.36"],["4N48_A_SAMA601_0","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","2iv2","FORMATE DEHYDROGENASE H","Escherichia coli",5,"GLY X 113;GLY X 111;THR X 116;ASN X 114;GLY X 107","None;2MD X 801 (-3.8A);None;None;None","1.15A","4n48A-2iv2X:undetectable","4jvlA-2iv2X:17.76"],["4N48_B_SAMB601_0","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","2iv2","FORMATE DEHYDROGENASE H","Escherichia coli",5,"GLY X 113;GLY X 111;THR X 116;ASN X 114;GLY X 107","None;2MD X 801 (-3.8A);None;None;None","1.12A","4n48B-2iv2X:undetectable","4n48A-2iv2X:21.10"],["4ZZC_A_ACTA401_0","PROTON-GATED ION CHANNEL","2iv2","FORMATE DEHYDROGENASE H","Escherichia coli",4,"ILE X 430;PHE X 431;ARG X  61;ILE X  52","2MD X 801 (-4.2A);None;None;None","1.00A","4zzcA-2iv2X:undetectable;4zzcB-2iv2X:undetectable","4n48B-2iv2X:21.10"],["4ZZC_B_ACTB401_0","PROTON-GATED ION CHANNEL","2iv2","FORMATE DEHYDROGENASE H","Escherichia coli",4,"ILE X 430;PHE X 431;ARG X  61;ILE X  52","2MD X 801 (-4.2A);None;None;None","1.08A","4zzcB-2iv2X:undetectable;4zzcC-2iv2X:undetectable","4zzcA-2iv2X:17.87;4zzcB-2iv2X:17.87"],["5AMI_B_EF2B151_1","CEREBLON ISOFORM 4","1tmo","TRIMETHYLAMINE N-OXIDE REDUCTASE","Shewanella massilia",4,"ASN A 443;PRO A 444;PHE A 439;SER A 440","2MD A 799 (-4.5A);None;None;2MD A 799 ( 4.4A)","0.65A","5amiB-1tmoA:undetectable","4zzcB-2iv2X:17.87;4zzcC-2iv2X:17.87"],["5EDL_A_VIBA201_1","PUTATIVE HMP\/THIAMINE PERMEASE PROTEIN YKOE","2iv2","FORMATE DEHYDROGENASE H","Escherichia coli",5,"TYR X  10;TRP X 448;ILE X 430;SER X 590;ARG X 110","None;None;2MD X 801 (-4.2A);2MD X 801 (-3.2A);2MD X 801 (-4.4A)","1.47A","5edlA-2iv2X:0.6","5amiB-1tmoA:9.59"],["5IKR_B_ID8B602_2","PROSTAGLANDIN G\/H SYNTHASE 2","2iv2","FORMATE DEHYDROGENASE H","Escherichia coli",3,"SER X 445;LEU X  75;MET X  66","2MD X 801 (-2.9A);None;None","0.70A","5ikrB-2iv2X:undetectable","5edlA-2iv2X:15.24"],["5LF7_B_6V8B304_0","PROTEASOME SUBUNIT BETA TYPE-6;PROTEASOME SUBUNIT BETA TYPE-7","1tmo","TRIMETHYLAMINE N-OXIDE REDUCTASE","Shewanella massilia",5,"THR A 474;THR A 472;ALA A 473;SER A 440;GLY A 441","None;2MD A 799 (-4.0A);None;2MD A 799 ( 4.4A);2MD A 799 (-3.7A)","1.13A","5lf7V-1tmoA:undetectable;5lf7b-1tmoA:undetectable","5ikrB-2iv2X:22.48"],["5LF7_N_6V8N305_0","PROTEASOME SUBUNIT BETA TYPE-6;PROTEASOME SUBUNIT BETA TYPE-7","1tmo","TRIMETHYLAMINE N-OXIDE REDUCTASE","Shewanella massilia",5,"THR A 474;THR A 472;ALA A 473;SER A 440;GLY A 441","None;2MD A 799 (-4.0A);None;2MD A 799 ( 4.4A);2MD A 799 (-3.7A)","1.13A","5lf7H-1tmoA:undetectable;5lf7N-1tmoA:undetectable","5lf7V-1tmoA:14.23;5lf7b-1tmoA:14.15"],["5N0O_A_SAMA501_1","PEPTIDE N-METHYLTRANSFERASE","1tmo","TRIMETHYLAMINE N-OXIDE REDUCTASE","Shewanella massilia",3,"ALA A 152;GLN A 333;THR A 761","None;2MD A 800 (-3.5A);None","0.71A","5n0oA-1tmoA:undetectable","5lf7H-1tmoA:14.23;5lf7N-1tmoA:14.15"],["5N4T_B_BEZB306_0","BETA-LACTAMASE VIM-2","1tmo","TRIMETHYLAMINE N-OXIDE REDUCTASE","Shewanella massilia",3,"HIS A 447;ASN A 446;ALA A 473","2MD A 799 (-4.2A);2MD A 799 (-3.8A);None","0.74A","5n4tB-1tmoA:undetectable","5n0oA-1tmoA:18.21"],["5XPR_A_K86A1201_2","ENDOTHELIN B RECEPTOR,ENDOLYSIN,ENDOTHELIN B RECEPTOR","1tmo","TRIMETHYLAMINE N-OXIDE REDUCTASE","Shewanella massilia",4,"ASP A 189;PRO A 652;GLU A 724;TYR A 771","None;2MD A 800 (-4.1A);2MD A 799 ( 4.5A);2MD A 799 (-4.8A)","1.44A","5xprA-1tmoA:0.0","5n4tB-1tmoA:14.09"],["6GIQ_T_PCFT101_0","CYTOCHROME B-C1 COMPLEX SUBUNIT 1, MITOCHONDRIAL;CYTOCHROME B-C1 COMPLEX SUBUNIT 9;CYTOCHROME B-C1 COMPLEX SUBUNIT RIESKE, MITOCHONDRIAL","1tmo","TRIMETHYLAMINE N-OXIDE REDUCTASE","Shewanella massilia",4,"MET A  50;GLY A 441;SER A 127;VAL A 469","None;2MD A 799 (-3.7A);2MD A 799 (-3.4A);None","0.94A","6giqL-1tmoA:undetectable;6giqP-1tmoA:undetectable;6giqT-1tmoA:undetectable","5xprA-1tmoA:20.39"]]